Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance via PTEN-mediated crosstalk between the PI3K/Akt and Erk/MAPKs signaling pathways in the skeletal muscles of db/db mice.

Abstract

BACKGROUND:

Globally, 1 in 11 adults have diabetes mellitus, and 90% of the cases are type 2 diabetes mellitus. Insulin resistance is a central defect in type 2 diabetes mellitus, and although multiple drugs have been developed to ameliorate insulin resistance, the limitations and accompanying side effects cannot be ignored. Thus, more effective methods are required to improve insulin resistance.

METHODS:

In the current study, db/m and db/db mice were injected with human umbilical cord-derived mesenchymal stem cells (HUC-MSCs) via tail vein injection, intraperitoneal injection, and skeletal muscle injection. Body weight, fasting blood glucose, and the survival rates were monitored. Furthermore, the anti-insulin resistance effects and potential mechanisms of transplanted HUC-MSCs were investigated in db/db mice in vivo.

RESULTS:

The results showed that HUC-MSC transplantation by skeletal muscle injection was safer compared with tail vein injection and intraperitoneal injection, and the survival rate reached 100% in the skeletal muscle injection transplanted mice. HUC-MSCs can stabilize localization and differentiation in skeletal muscle tissue and significantly ameliorate insulin resistance. Potential regulatory mechanisms are associated with downregulation of inflammation, regulating the balance between PI3K/Akt and ERK/MAPK signaling pathway via PTEN, but was not associated with the IGF-1/IGF-1R signaling pathway.

CONCLUSIONS:

These results suggest HUC-MSC transplantation may be a novel therapeutic direction to prevent insulin resistance and increase insulin sensitivity, and skeletal muscle injection was the safest and most effective way.

• Authors: Guang Chen, Xiao-Yan Fan, Xiao-Peng Zheng, Yue-Lei Jin, Ying Liu, Shuang-Chun Liu
• Journal: Stem cell research & therapy (Stem Cell Res Ther) Vol. 11 Issue 1 Pg. 401 (09 16 2020) ISSN: 1757-6512 [Electronic] England
• PMID: 32938466 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Proto-Oncogene Proteins c-akt
• PTEN Phosphohydrolase

Topics

• Animals
• Diabetes Mellitus, Type 2
• Humans
• Insulin Resistance
• Mesenchymal Stem Cell Transplantation
• Mesenchymal Stem Cells
• Mice
• Muscle, Skeletal (physiology)
• PTEN Phosphohydrolase (genetics)
• Phosphatidylinositol 3-Kinases (genetics)
• Proto-Oncogene Proteins c-akt (genetics)
• Signal Transduction
• Umbilical Cord (cytology)